@article{f31dd1091ee7417ea8ccf0918f8796a7,
title = "Synaptosomal-Associated Protein 25 kDA (SNAP-25) Levels in Cerebrospinal Fluid: Implications for Alzheimer's Disease Diagnosis and Monitoring",
abstract = "Synaptic degeneration has been linked to cognitive decline. The presynaptic protein, synaptosomal-associated protein 25 kDA (SNAP-25), is crucial for synaptic transmission and has been suggested as a biomarker in Alzheimer's disease (AD). In the current study, we investigated the ability of SNAP-25 to differentiate between heterogenous dementia etiologies and whether SNAP-25 could be a staging marker in AD. SNAP-25 in the cerebrospinal fluid (CSF) from a retrospective (n = 187) and a prospective (n = 134) cohort was investigated with immunoprecipitation mass spectrometry (IP-MS) and single-molecule array (Simoa), respectively. Both cohorts consisted of healthy controls (HC) and patients with cognitive decline of different etiologies. CSF SNAP-25 concentration was higher in AD and non-neurodegenerative diseases (i.e., vascular dementia) compared with controls but did not differ between AD and non-AD neurodegenerative diseases. We found a trend toward an association between SNAP-25 and disease burden when comparing HC, mild cognitive impairment due to AD, and AD. CSF SNAP-25 concentrations were strongly associated with CSF phosphorylated tau (p-tau) concentrations, thus strengthening the link between synaptic dysfunction and tau pathophysiology in AD. Our initial findings suggest that SNAP-25 may be a potential biomarker for differentiating AD from dementia due to other etiologies. However, due to the significant association between SNAP-25 and p-tau proteins, the clinical utility of SNAP-25 as a diagnostic biomarker for AD may be limited, while SNAP-25 may be useful for monitoring disease progression or treatment response.",
keywords = "Synaptosomal-Associated Protein 25/cerebrospinal fluid, Alzheimer Disease/cerebrospinal fluid, Humans, Aged, Female, Male, Middle Aged, Biomarkers/cerebrospinal fluid, Retrospective Studies, Cognitive Dysfunction/cerebrospinal fluid, tau Proteins/cerebrospinal fluid, Prospective Studies, Aged, 80 and over, Snap-25, Csf, Diagnosis, Alzheimer's disease",
author = "Wolner, \{Sofia Hjorth\} and Gleerup, \{Helena Sophia\} and Musaeus, \{Christian Sand{\o}e\} and Peter H{\o}gh and Ashton, \{Nicholas J\} and Ann Brinkmalm and Johanna Nilsson and Lana Gr{\"o}tschel and Henrik Zetterberg and Kaj Blennow and Hasselbalch, \{Steen Gregers\} and Walls, \{Anne Byriel\} and Simonsen, \{Anja Hviid\}",
note = "{\textcopyright} 2025 The Author(s). Synapse published by Wiley Periodicals LLC.",
year = "2025",
month = mar,
doi = "10.1002/syn.70010",
language = "English",
volume = "79",
journal = "Synapse",
issn = "0887-4476",
publisher = "Wiley-Liss Inc.",
number = "2",
}